Momenta Phamaceuticals (MNTA) Tops Q4 EPS by 6c
Tweet
Share
E-mailGet Alerts MNTA Hot Sheet
Price: $52.48 --0%
Financial Fact:
Total other income (expense): 638K
Today's EPS Names:
SFST, VLTO, CLIR, More
Financial Fact:
Total other income (expense): 638K
Today's EPS Names:
SFST, VLTO, CLIR, More
Join SI Premium – FREE
Momenta Phamaceuticals, Inc. (NASDAQ: MNTA) reported Q4 EPS of ($0.35), $0.06 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $12.7 million versus the consensus estimate of $10.41 million. Momenta Phamaceuticals, Inc. reaffirmed FY2013 guidance.
For earnings history and earnings-related data on Momenta Phamaceuticals, Inc. (MNTA) click here.
For earnings history and earnings-related data on Momenta Phamaceuticals, Inc. (MNTA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lockheed Martin (LMT) Tops Q1 EPS by 53c, Beats on Revenue; Offers FY24 Guidance
- Sherwin-Williams (SHW) Misses Q1 EPS by 5c, provides guidance
- NextEra Energy (NEE) Tops Q1 EPS by 16c, provides guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
